This application seeks to understand how the brain, through signals delivered via sympathetic neurons, controls immune function. The sympathetic nervous system controls a variety of cellular and metabolic functions and plays a critical role in the flight or fight response. The adrenergic class of neurotransmitter receptors binds to nor-epinephrine secreted by sympathetic neurons and is a target of various pharmacological agonists and antagonists used in humans. Very little is known about how this pathway interfaces with the immune system. We recently found selective expression of the ?2-adrenergic receptor (ADRB2) on human CD8+ memory T cells, and it is also expressed in murine CD8+ T cells. Signaling through this receptor significantly suppressed various effector T cell functions including cytokine secretion and lytic activity. Further, CD8+ CTLs lacking the ADRB fail to generate memory cells following infection with vesicular stomatitis virus. Given the importance of this pathway in regulating multiple physiological processes, we wished to determine the role of the ADRB2 in regulating the major functions of adaptive cytolytic T cells of the immune system.
Aim 1 will determine how intrinsic ADRB2 signaling regulates the development and function of both effector and memory CD8+ CTLs in response to intracellular infections.
Aim 2 will identify the molecular pathway that drives ADRB2-mediated memory development. Finally, Aim 3 will determine how long-acting ?-agonist drugs alter the course of a primary and secondary immune response to flu infection. These studies will inform us on the role of the sympathetic nervous system in regulating cytolytic T cell function and how pharmacological agonists alter those responses.

Public Health Relevance

? PUBLIC HEALTH RELEVANCE STATEMENT While we instinctively know that mental and emotional well being affect the immune system, very little is actually known about how the nervous system controls immune function. In fact, this is an area of great controversy and debate among scientists. In this proposal, we present compelling preliminary evidence that T cells of the adaptive immune system respond to neural signals via the ?2 adrenergic receptor, which bind norepinephrine secreted by sympathetic neurons that innervate lymphoid tissues. This proposal seeks to directly test how this receptor acting through the sympathetic nervous system controls immune function in response to pathogenic organisms.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
1R56AI125545-01
Application #
9333814
Study Section
Cellular and Molecular Immunology - A Study Section (CMIA)
Program Officer
Kelly, Halonna R
Project Start
2016-09-01
Project End
2017-08-31
Budget Start
2016-09-01
Budget End
2017-08-31
Support Year
1
Fiscal Year
2016
Total Cost
$392,972
Indirect Cost
$142,972
Name
University of Texas Sw Medical Center Dallas
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
A?aç, Didem; Estrada, Leonardo D; Maples, Robert et al. (2018) The ?2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion. Brain Behav Immun 74:176-185
Estrada, Leonardo D; A?aç, Didem; Farrar, J David (2016) Sympathetic neural signaling via the ?2-adrenergic receptor suppresses T-cell receptor-mediated human and mouse CD8(+) T-cell effector function. Eur J Immunol 46:1948-58